Quantification of (+)-calanolide A, a novel and naturally occurring anti-HIV agent, by high-performance liquid chromatography in plasma from rat, dog and human

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 742, Issue 2, 2000, Pages 267-275

  Xu, Ze Qi ^a   Norris, Kenneth J ^b   Weinberg, David S ^c   Kardatzke, Janis ^b   Wertz, Paul ^b   Frank, Patricia ^a   Flavin, Michael T ^a  

^a MediChem Research Inc   (United States)

^b Analytical Development Corporation   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Calanolide A

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CALANOLIDE A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-HIV AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; COUMARINS; DOGS; FEMALE; HIV SERONEGATIVITY; HUMANS; MALE; PYRANOCOUMARINS; RATS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE;

EID: 0034625699     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(00)00170-5     Document Type: Article

References (15)

1. Kashman Y., Gustafson K.R., Fuller R.W., Cardellina II J.H., McMahon J.B., Currens M.J., Buckheit R.W., Hughes S.H., Cragg G.M., Boyd M.R. J. Med. Chem. 35:1992;2735.
2. Flavin M.T., Rizzo J.D., Khilevich A., Kucherenko A., Sheinkman A.K., Vilaychack V., Lin L., Chen W., Greenwood E.M., Pengsuparp T., Pezzuto J.M., Hughes S.H., Flavin T.M., Cibulski M., Boulanger W.A., Shone R.L., Xu Z.-Q. J. Med. Chem. 39:1996;1303.
3. Currens M.J., Gulakowski R.J., Mariner J.M., Moran R.A., Buckheit R.W. Jr., Gustafson K.R., McMahon J.B., Boyd M.R. J. Pharmacol. Exp. Ther. 279:1996;645.
4. Boyer P.L., Currens M.J., McMahon J.B., Boyd M.R., Hughes S.H. J. Virol. 67:1993;2412.
5. Hizi A., Tal R., Shaharabany M., Currens M.J., Boyd M.R., Hughes S.H., McMahon J.B. Antimicrob. Agents Chemother. 37:1993;1037.
6. Currens M.J., Mariner J.M., McMahon J.B., Boyd M.R. J. Pharmacol. Exp. Ther. 279:1996;652.
7. Buckheit R.W. Jr., Fliakas-Boltz V., Decker W.D., Roberson J.L., Stup T.L., Pyle C.A., White E.L., McMahon J.B., Currens M.J., Boyd M.R., Bader J.P. Antiviral Res. 26:1995;117.
8. Buckheit R.W. Jr., Fliakas-Boltz V., Decker W.D., Roberson J.L., Pyle C.A., White E.L., Bowdon B.J., McMahon J.B., Boyd M.R., Bader J.P., Nickell D.G., Barth H., Antonucci T.K. Antiviral Res. 25:1994;43.
9. Buckheit R.W. Jr., Fliakas-Boltz V., Yeagy-Bargo S., Weislow O., Mayers D.L., Boyer P.L., Hughes S.H., Pan B.-C., Chu S.-H., Bader J.P. Virology. 210:1995;186.
10. Buckheit R.W. Jr., Kilnjerski T.L., Fliakas-Boltz V., Russell J.D., Stup T.L., Palansch L.A., Brouwer W.G., Dao D.C., Harrison W.A., Schultz R.J., Bader J.P., Yang S.S. Antimicrob. Agents Chemother. 39:1995;2718.
11. Xu Z.-Q., Hollingshead M.G., Borgel S., Elder C., Khilevich A., Flavin M.T. Bioorg. Med. Chem. Lett. 9:1999;133.
12. Frank P., Flavin M.T., Roca-Actin J., Xu Z.-Q. 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC :22-26 January 1997;. Abstract 225.
13. Creagh T., Xu Z.-Q., Ray L., Giltner J., Nayer T., Ruckle J. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL :1-5 February 1998;. Abstract 652.
14. Newman R.A., Chen W., Madden T.L. J. Pharm. Sci. 87:1998;1077-1080.
15. Xu Z.-Q., Buckheit R.W. Jr., Stup T.L., Flavin M.T., Khilevich A., Rizzo J.D., Lin L., Zembower D.E. Bioorg. Med. Chem. Lett. 8:1998;2179.